Flomax Generics Due Next Year
BPH Market War Simmering; AEterna Slips, More to Come
By Randy Osborne
Monday, August 24, 2009
Prostate cancer, deadly though sometimes slow-moving, gets far more press, but benign prostatic hyperplasia - enlargement (usually associated with age) of the male gland that contributes alkalinity to sperm fluid, letting the reproductive tadpoles swim longer - represented a $3.7 billion market last year. And plenty of players are on the case.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.